The National National Task Force for COVID-19 of ICMR has made the decision to not include the antiviral drug Molnupiravir in the Clinical Management Protocol for now, official sources told news agency PTI on Tuesday (January 11).
ICMR excludes Molnupiravir from COVID-19 clinical management protocol
